Roper Technologies Inc Stock News

Roper Technologies (ROP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SARASOTA, Fla., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (NYSE: ROP) today announced that it will host an investor day on March 21, 2023 in New York. The event is scheduled to begi

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Check out the companies which changed their dividends.

Strength across the Deltek, Vertafore, Aderant, CliniSys, Data Innovations, Foundry and Neptune businesses, and the Frontline acquisition augur well for Ropers' (ROP) growth.

2022 wasn't a banner year for most investors. Major American equity markets fell into bear market territory.

Novo Nordisk, AstraZeneca, Accenture, Chubb and Roper Technologies are part of the Zacks top Analyst Blog.

Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), AstraZeneca PLC (AZN) and Accenture plc (ACN).

A look at some of the top industrial ETFs.

Investors could hit the jackpot if the pieces fall into place.

Water stocks are an interesting breed. Water is an essential good, and there are lots of companies that make money off of water in one way or another.

SARASOTA, Fla., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (NYSE: ROP) announced that it is presenting at the Raymond James Technology Investors Conference on Wednesday, December 7,

SARASOTA, Fla., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (NYSE: ROP) announced that it is presenting at the Raymond James Technology Investors Conference on Wednesday, December 7, at

Roper (ROP) is poised for growth on the back of strength across all its segments, acquired assets and portfolio restructuring initiatives. The company's efforts to add shareholder value hold promise.

Roper (ROP) is poised for growth on the back of strength across all its segments, acquired assets and portfolio restructuring initiatives. The company's efforts to add shareholder value hold promise.

Healthy market conditions have helped the company generate higher organic sales growth in the third quarter of 2022. In the fourth quarter of 2022, the company completed the acquisition of Frontline E